Workflow
Newsfile
icon
Search documents
DLP Resources Announces Intersection of 260.50m of 1.02% CuEq* Within 866.95m Interval of 0.55% CuEq*, on the Aurora Project
Newsfile· 2025-12-11 11:00
Core Viewpoint - DLP Resources Inc. has announced significant drill results from the Aurora Project, indicating successful mineralization of copper, molybdenum, and silver, with plans to update the Mineral Resource estimate and complete a Preliminary Economic Assessment (PEA) by Q1 2026 [1][3]. Summary of Drill Results - Drillhole A25-026 intersected 1.02% CuEq over 260.50m within a total interval of 866.95m averaging 0.55% CuEq [5][8]. - Drillhole A25-027 showed 0.42% CuEq over 679.20m, with notable intervals of 0.36% CuEq over 370.00m and 0.48% CuEq over 547.20m [5][8]. Geological Context - The Aurora Project is characterized by mineralized hornfels and porphyry, with significant intervals of copper and molybdenum mineralization identified in both drillholes [6][10]. - Historical drilling data indicates that previous drilling efforts primarily tested leached zones, with only a few holes reaching the primary copper and molybdenum zones [17][19]. Future Plans - The company is on track to update the initial Mineral Resource Estimate and complete the PEA by Q1 2026, with ongoing geological model reviews and infrastructure assessments [3][15][16]. Quality Control Measures - DLP Resources has implemented rigorous quality control and assurance protocols, including the use of certified reference materials and independent laboratory analysis to ensure data reliability [13][14]. Company Overview - DLP Resources Inc. is focused on mineral exploration in Southeastern British Columbia and Peru, targeting base metals and cobalt, and is publicly traded on TSX-V, OTCQB, and FSE [30].
St. Augustine Announces Closing of Private Placement
Newsfile· 2025-12-11 11:00
Manila, Philippines--(Newsfile Corp. - December 11, 2025) - St. Augustine Gold and Copper Limited (TSX: SAU) ("St. Augustine" or the "Company") is pleased to announce that it has closed the previously announced private placement of $1,204,500 from the sale of 16.5 million units, each unit comprising one common share and two warrants, each warrant entitling the holder to subscribe for one additional common share at $0.11 for a period of 5 years, assuming a number of development milestones are met during tha ...
RETRANSMISSION: HIVE Digital Technologies Enters Colombia's Deep Andean Capital Markets With Colombia Listing, Advancing Its Role as Latin America's Emerging Leader in Green AI and Bitcoin Infrastructure
Newsfile· 2025-12-11 11:00
RETRANSMISSION: HIVE Digital Technologies Enters Colombia's Deep Andean Capital Markets With Colombia Listing, Advancing Its Role as Latin America's Emerging Leader in Green AI and Bitcoin InfrastructureThis news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025.December 11, 2025 6:00 AM EST | Source: HIVE Digital Technologies Ltd.San Antonio, Texas--(New ...
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing
Newsfile· 2025-12-11 10:00
Core Insights - Focus Graphite Inc. has achieved ultra-high purity levels of 99.9996 wt.% (5N+) and an Equivalent Boron Concentration (EBC) of 2.03 ppm from its Lac Knife deposit, confirming its potential as a source for advanced materials in North America [2][4][5] - The purification process utilized is environmentally friendly, employing electrothermal methods without halogen gases or acids, which supports the company's commitment to sustainable practices [3][6] - The results position Lac Knife graphite as a competitive alternative to synthetic graphite in high-margin markets, including nuclear energy, defense, and advanced electronics [6][11] Purity and Quality - The achieved EBC of 2.03 ppm is below the critical threshold of 3 ppm for nuclear-grade applications, indicating the material's suitability for high-value markets [4][5] - The combination of 5N+ purity and large flake distribution is rare in the natural graphite industry, providing Focus Graphite with unique market opportunities [5][11] Market Applications - Lac Knife graphite is positioned for various advanced industrial applications, including nuclear energy, graphene production, and defense systems [6][8][12] - In the graphene sector, the high purity of Lac Knife graphite allows for the production of high-quality graphene structures, with a record-high yield of 22% ± 3% in follow-on testing [10][11] - The defense sector presents significant opportunities, as high-purity graphite can be used in obscuration systems and stealth coatings, with potential procurement values reaching approximately US$30,000 per ton [12][15] Technical Validation and Future Steps - Focus Graphite is advancing a technical qualification program to further assess Lac Knife's suitability for nuclear and advanced material markets, including detailed characterization of various performance parameters [19][20] - The company is exploring additional high-value markets, such as thermal management components and semiconductor applications, where ultra-high purity is critical [18][20] Company Overview - Focus Graphite is focused on redefining the future of critical minerals with its Lac Knife project, which is recognized as one of the most advanced high-purity graphite deposits in North America [27][28] - The company is committed to environmentally sustainable processing solutions and innovative battery technologies, aiming to secure a resilient supply of critical minerals [29]
Herbal Dispatch Unveils Strategic Business Plan for 2026 to Drive Sustainable Growth and Enhance Shareholder Value
Newsfile· 2025-12-11 08:01
Core Insights - Herbal Dispatch Inc. has announced a comprehensive Strategic Business Plan for 2026 aimed at driving sustainable growth and enhancing shareholder value, building on its strong historical performance and aiming for significant revenue acceleration while improving gross margins and EBITDA [1][2] Strategic Priorities - **Enhancing Medical Cannabis Sales to Veterans**: The company plans to increase sales in this segment by 200% annually through partnerships with veterans' organizations, development of veteran-specific product bundles, and targeted marketing campaigns. Key performance indicators (KPIs) include 30% year-over-year growth in veteran customer acquisition and maintaining a retention rate above 89% [2][3] - **Expanding Recreational Sales**: Herbal Dispatch aims for 40% year-over-year growth in recreational sales by securing listings with additional provincial cannabis wholesalers and expanding SKU counts in British Columbia from 44 to over 100. KPIs include entering new provinces and boosting British Columbia's market share to 15% [2][5] - **Growing B2B Exports**: The company targets tripling export volumes by 2028, focusing on strengthening partnerships in existing markets and entering new markets. KPIs include 100% year-over-year export revenue growth and adding 2-3 new markets annually [5][6] - **Increasing Investor Awareness**: Herbal Dispatch will engage specialized investor relations and marketing firms to enhance liquidity and attract institutional investors, including quarterly webinars and updated investor materials [6][10] Market Position - Herbal Dispatch holds a unique position among Canadian public cannabis companies, with the longest growth runway in the sector. The company is positioned to simultaneously double medical sales and provincial footprint while tripling exports, which are opportunities that competitors have already exhausted [7][8] Execution Strategy - To execute its strategic priorities, Herbal Dispatch has engaged a coordinated team of agencies, allocating approximately CAD $410,000 for these initiatives, funded from existing working capital [12][13]
HIVE Digital Technologies Enters Colombia's Deep Andean Capital Markets With Colombia Listing, Advancing Its Role as Latin America's Emerging Leader in Green AI and Bitcoin Infrastructure
Newsfile· 2025-12-11 06:00
Core Insights - HIVE Digital Technologies Ltd. is expanding its presence in Latin America by listing on the Colombian Stock Exchange, becoming the first Bitcoin and AI infrastructure company to do so, which enhances its visibility among investors seeking sustainable computing solutions [2][3][4] Company Expansion - The Colombian Stock Exchange is recognized as one of the deepest and most institutionally connected exchanges in the region, providing enhanced access and cross-border liquidity for investors [2] - HIVE operates across nine time zones and five languages, with infrastructure in Canada, Sweden, and Paraguay, which strengthens its regulatory agility and operational resilience [10] Strategic Positioning - HIVE's recent listing marks a strategic inflection point, opening a new capital-markets channel for investors in the interconnected Andean exchanges of Colombia, Peru, and Chile [12] - The company reported record quarterly revenue of $87.3 million, reflecting approximately 285% year-over-year growth, driven by strong Bitcoin production and demand for its BUZZ HPC cloud platform [13] Technological Convergence - HIVE is transitioning from Tier I Bitcoin mining to Tier III AI and HPC cloud infrastructure, capitalizing on the convergence between digital-asset computation and industrial AI [14] - The company is scaling its GPU capacity across renewable power, with plans to deploy over 36,000 GPUs dedicated to AI and HPC cloud services [14] Community and Sustainability Initiatives - HIVE's expansion in Paraguay aims to scale toward 400 MW of renewable capacity, focusing on local hiring, educational partnerships, and green-energy programs to support economic development [11] - The company emphasizes building responsible and sustainable digital infrastructure in Latin America, aligning with the region's growing technology footprint [12]
ROSEN, A RANKED AND LEADING FIRM, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRGO
Newsfile· 2025-12-11 04:20
Core Points - Rosen Law Firm is reminding investors of Perrigo Company plc about the January 16, 2026 deadline to join a securities class action lawsuit related to the company's performance during the class period from February 27, 2023, to November 4, 2025 [2][3] Group 1: Class Action Details - Investors who purchased Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3] - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by January 16, 2026 [4] - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from underinvestment and significant manufacturing deficiencies [6] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [5] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [5]
MLTX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX
Newsfile· 2025-12-11 04:03
Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics to secure legal counsel before the December 15, 2025 deadline for a securities class action related to the company's stock performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased MoonLake common stock between March 10, 2024, and September 29, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - The lawsuit claims that during the class period, the defendants made false or misleading statements regarding the efficacy of their product SLK compared to traditional monoclonal antibodies, leading to investor damages when the truth was revealed [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a notable settlement against a Chinese company and has recovered hundreds of millions for investors over the years [4].
Stardust Solar Announces Closing of Shares for Debt
Newsfile· 2025-12-11 01:15
Core Points - Stardust Solar Energy Inc. has issued 468,000 common shares at a price of $0.10 per share to settle a debt of $46,800 for legal services [1] - The shares issued are subject to a statutory hold period of four months plus a day, ending on April 11, 2026 [2] Company Overview - Stardust Solar is a North American franchisor specializing in renewable energy installation services, including solar panels, energy storage systems, and electric vehicle supply equipment [3] - The company provides entrepreneurs with branded business management services, advanced equipment, and comprehensive support in marketing, sales, engineering, and project management [3] - Stardust Solar aims to promote the adoption of clean energy solutions, contributing to economic development and sustainability [3]
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
Newsfile· 2025-12-11 01:00
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate UpdateDecember 10, 2025 8:00 PM EST | Source: Quantum BioPharma Ltd.Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol m ...